Day: January 4, 2022
VANCOUVER, British Columbia, Jan. 04, 2022 (GLOBE NEWSWIRE) — Treatment.com International Inc. (“Treatment” or the “Company”) (CSE: TRUE), (OTC: TREIF), a healthcare AI technology company, has entered into a research project agreement with the University of Minnesota to add more than 220 dermatologic diseases to their proprietary, responsive AI engine known as the Global Library of Medicine (GLM). The addition of these diagnoses will bring another level of accuracy and specificity to the GLM, enhancing soon-to-be-released products such as the Treatment Mobile app, which is set for release this month.
Kevin A. Peterson, MD, MPH, FRCS(Ed), FAAFP and Chief Medical Officer of Treatment, says, “Engaging in research with the University of Minnesota Dermatology department brings extensive academic medical expertise that enhances our ability...
First Citizens Completes Merger With CIT Group
Written by Customer Service on . Posted in Mergers And Acquisitions.
Frank B. Holding Jr., First Citizens chairman and chief executive officer“This is a transformational milestone in our 124-year history,” Holding said.Ellen R. Alemany, First Citizens vice chairwomanEllen R. Alemany, former chairwoman and chief executive officer of CIT, assumes the role of vice chairwoman of First Citizens (along with current First Citizens Vice Chairwoman Hope Holding Bryant) and will serve on the First Citizens Board of Directors.Michael A. CarpenterCarpenter will serve on the First Citizens BancShares Board of Directors.Vice Admiral John R. Ryan, USN (Ret.)Ryan will serve on the First Citizens BancShares Board of Directors.Marisa J. Harney, First Citizens chief credit officerHarney is now a member of the First Citizens executive leadership...
Annual General Meeting of RTX to be held on 27 January 2022
Written by Customer Service on . Posted in Public Companies.
Noerresundby, Denmark, 4 January 2022Announcement no. 01/2022
Enclosed please find a notice convening the Annual General Meeting of RTX to be held on Thursday 27 January 2022 at 3.00 pm at the Company’s address: Stroemmen 6, Noerresundby.
Best regards,RTX A/S
Peter Røpke CEO
Questions and further information: Peter Røpke, CEO, tel. +45 96 32 23 00
Please visit RTX’s website at: www.rtx.dkAttachmentRTX CA No 01-2022 – 04.01.22 – Notice of AGM with agenda and complete proposals
UTStarcom Announces Progress in Cooperation with China Unicom Research Institute on Development of 5G Transport Network Solution
Written by Customer Service on . Posted in Public Companies.
HANGZHOU, China, Jan. 04, 2022 (GLOBE NEWSWIRE) — UTStarcom (“UTStarcom” or the “Company”) (NASDAQ:UTSI), a global telecommunications infrastructure provider, today announced progress with China Unicom Research Institute in their cooperative development and field testing of a disaggregated networking solution for 5G transport networks. China Unicom Research Institute is a wholly owned subsidiary of China Unicom, one of the major mobile network operators (“MNO”) in China.
As a relatively new technology, the disaggregation of hardware and software in telecommunication networks is drawing serious interest in the telecom industry, especially for 5G transport networks. Disaggregation promises many benefits, such as the potential to reduce the capital commitment and operating costs of transport networks, eliminating vendor lock-in, speeding...
Allena Pharmaceuticals Provides Clinical and Corporate Update
Written by Customer Service on . Posted in Public Companies.
ALLN-346, an orally administered enzyme in development for the treatment of hyperuricemia and gout, demonstrates a statistically significant reduction in serum uric acid and a well-tolerated safety profile in first cohort of patients with hyperuricemia and chronic kidney disease in the Phase 2a Study 201Allena to host webinar to discuss the initial Study 201 data with Key Opinion Leaders Robert Terkeltaub, M.D. and David S. Goldfarb, M.D. today at 8:00 am ET; log-in information below
ALLN-346 Phase 2a Study 202 is actively enrolling patients with gout and stages 2 and 3 chronic kidney disease in parallel cohorts; data from both cohorts expected in Q1 2022
Company currently evaluating potential modifications to the pivotal URIROX-2 Phase 3 trial of Reloxaliase in Enteric Hyperoxaluria in an effort to reduce the size and duration of...
Verizon and Google team up to help unlock value for remote workforces with BlueJeans on Glass Enterprise Edition 2 and Google Pixel
Written by Customer Service on . Posted in Public Companies.
What you need to know:BlueJeans Meetings now comes preloaded on Glass Enterprise Edition 2 devices sold by Verizon
Combination of Google Pixel, Glass Enterprise Edition 2 and BlueJeans Meetings unleashes new, hands-free way to visualize the world around you
When powered by 5G mobile connectivity, Google Pixel 6 with BlueJeans Meetings on Glass maximizes productivity and minimizes error rates in frontline workersNEW YORK, Jan. 04, 2022 (GLOBE NEWSWIRE) — Verizon Business today announced BlueJeans Meetings is now available for Glass Enterprise Edition 2*. Coming soon, business customers can purchase Glass Enterprise Edition 2 with BlueJeans preloaded* from Verizon for $1,139.99 to integrate glass wearables into the new ways of working. For a limited time, customers can get up to $700 off Glass Enterprise Edition 2 when purchased...
At 15.6% CAGR, Vehicle Telematics Market Size [2022-2028] is Projected to Grow USD 179.50 Billion
Written by Customer Service on . Posted in Mergers And Acquisitions.
Vehicle Telematics Market Key Companies Analyzed in this Report Are Robert Bosch GmbH (Gerlingen, Germany), Webfleet Solutions B.V. (Amsterdam, North Holland), MiX Telematics (Midrand, South Africa), Trimble (California, U.S.), Verizon (New York, U.S.), Zonar Systems (Washington, U.S.), Octo Group S.p.A (Rome, Italy), Microlise Telematics Pvt. Ltd. (Nottingham, U.K.), Omnitracs (Texas, U.S.), Masternaut Limited (London, U.K.).
Pune, India, Jan. 04, 2022 (GLOBE NEWSWIRE) — According to the report by Fortune Business Insights, the global Vehicle Telematics market size was USD 58.69 billion in 2020. The market is projected to grow from USD 64.93 billion in 2021 to USD 179.50 billion in 2028 growing at a CAGR of 15.6% over the forecast period.
The rising demand for smartphone characteristics in the automobile, automated driving technologies...
Turnover of Apranga Group in December 2021 and total year 2021
Written by Customer Service on . Posted in Public Companies.
The retail turnover (including VAT) of Apranga Group amounted to EUR 25.6 million in December 2021 and has increased by 87.0% in comparison to December 2020.
Due to epidemic coronavirus (COVID-19) infection, from 16 December 2020, all the Group’s stores in Lithuania were temporarily closed. Stores in Lithuania with a separate entrance from outside and a sales area not exceeding 300 square meters had been open since 15 February 2021. All stores with a separate entrance from outside had been open since 15 March 2021. All Group’s stores have been reopened in Lithuania from 19 April 2021, however, stores operating in shopping malls were not allowed to work on weekends, unless they had separate entrance from outside. Eventually, all Group’s stores have been open in Lithuania as of 29 May 2021. In Latvia, stores were temporarily closed from...
POC Coagulation Testing Devices Market Size [2022-2028] | is Estimated to Reach USD 2.44 Billion in 2028 with 6.9% CAGR
Written by Customer Service on . Posted in Mergers And Acquisitions.
Key Companies in POC Coagulation Testing Devices Market are Werfen (Barcelona, Spain), CoaguSense, Inc. (California, U.S.), Helena Laboratories Corporation (Texas, U.S.), Medtronic (Dublin, Ireland), Abbott (Illinois, U.S.), F. Hoffmann-La Roche Ltd (Basel, Switzerland), Siemens Healthcare GmbH (Munich, Germany), Koninklijke Philips N.V. (Amsterdam, Netherlands), HemoSonics, LLC (Virginia, U.S.), Haemonetics Corporation (Boston, U.S.)
Pune, India, Jan. 04, 2022 (GLOBE NEWSWIRE) — The global POC Coagulation Testing Devices Market size is estimated to reach USD 2.44 billion in 2028. The market size was USD 1.50 billion in 2020 whereas it is estimated to be USD 1.53 billion in 2021. Furthermore, the market registered a CAGR of 6.9% in the 2021-2028 period. This information is provided by Fortune Business Insights™, in its report,...
Total Assets Value
Written by Customer Service on . Posted in Public Companies.
PayPoint Plc (the “Company”) – Total Voting Rights
In conformity with DTR 5.6.1 the Company hereby notifies the market of the following:
As at 31 December 2021, the Company’s capital consisted of 68,747,474 ordinary shares with voting rights.
The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA’s Disclosure Guidance and Transparency Rules.
Enquiries:
PayPoint Plc
Sarah Carne, Company Secretary
+44(0)1707 600300
LEI: 5493004YKWI8U0GDD138
http://corporate.paypoint.com/